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Background and aims: Fasting insulin (FI), fasting glucose (FG), systolic blood pressure (SBP), high density
lipoproteins (HDL), triacylglycerides (TAG), and body mass index (BMI) are well-known risk factors for type 2 diabetes.
Reliable estimates of lifestyle intervention effects on these factors allow diabetes risk to be predicted accurately.
The present meta-analyses were conducted to quantitatively summarize effects of diet and exercise intervention
programs on FI, FG, SBP, HDL, TAG and BMI in adults without diabetes.
Materials and methods: MEDLINE and EMBASE were searched to find studies involving diet plus exercise
interventions. Studies were required to use adults not diagnosed with type 2 diabetes, involve both dietary and
exercise counseling, and include changes in diabetes risk factors as outcome measures. Data from 18, 24, 23, 30, 29
and 29 studies were used for the analyses of FI, FG, SBP, HDL, TAG and BMI, respectively. About 60% of the studies
included exclusively overweight or obese adults. Mean age and BMI of participants at baseline were 48 years and
30.1 kg/m2. Heterogeneity of intervention effects was first estimated using random-effect models and explained
further with mixed-effects models.
Results: Adults receiving diet and exercise education for approximately one year experienced significant (P <0.001)
reductions in FI (−2.56 ± 0.58 mU/L), FG (−0.18 ± 0.04 mmol/L), SBP (−2.77 ± 0.56 mm Hg), TAG (−0.258 ± 0.037 mmol/L)
and BMI (−1.61 ± 0.13 kg/m2). These risk factor changes were related to a mean calorie intake reduction of 273 kcal/d, a
mean total fat intake reduction of 6.3%, and 40 minutes of moderate intensity aerobic exercise four times a week.
Lifestyle intervention did not have an impact on HDL. More than 99% of total variability in the intervention
effects was due to heterogeneity. Variability in calorie and fat intake restrictions, exercise type and duration,
length of the intervention period, and the presence or absence of glucose, insulin, or lipid abnormalities
explained 23-63% of the heterogeneity.
Conclusions: Calorie and total fat intake restrictions coupled with moderate intensity aerobic exercises
significantly improved diabetes risk factors in healthy normoglycemic adults although normoglycemic adults with
glucose, insulin, and lipid abnormalities appear to benefit more.* Correspondence: ranga.appuhamy@gmail.com
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High prevalence of type 2 diabetes is strongly associated
with obesity and lack of physical activity. Type 2 diabetes
is a major cause of kidney failure, lower-limb amputa-
tion, blindness, heart disease and is a leading cause of
death among adults in Western countries [1]. Conse-
quently, diabetes creates a major financial burden on
national healthcare systems representing, for example,
more than 10% of total healthcare expenditures in the
USA, Canada and Europe [2].
Type 2 diabetes is a predictable and preventable dis-
ease [3]. In addition to pharmacological interventions,
type 2 diabetes can be effectively prevented or delayed
by lifestyle changes targeting diet and physical activity
improvements [4]. Increases in fasting insulin (FI), fasting
glucose (FG), systolic blood pressure (SBP), high density
lipoproteins (HDL), triacylglycerides (TAG), and body mass
index (BMI) are associated with increased risk of develop-
ing diabetes and are often used in mathematical models for
predicting the risk of developing diabetes [5-7]. Reliable es-
timates of risk factor responses to lifestyle interventions
can improve the accuracy of diabetes risk predictions and
assist in planning effective diabetes prevention programs.
Several published studies have investigated the effects
of diet and exercise interventions on diabetes risk factors
but the estimated effect sizes are inconsistent across
studies. Meta-analyses are widely used to compare and
combine treatment effects across studies and achieve con-
sensus about the overall treatment effect size. However,
conclusions drawn from combining data can be mislead-
ing, especially if the individual studies and datasets are
considerably different. Therefore, estimation and explan-
ation of the between-study variability or heterogeneity of
effect sizes should be an important goal in undertaking
meta-analyses. Meta-analyses using random-effect models
assume that the studies are a random sample of the entire
population of studies, allowing inferences to be general-
ized beyond the studies included. Random-effect meta-
analyses also allow for estimation and exploration of het-
erogeneity [8].
Meta-analyses have previously been published on life-
style intervention effects in adults diagnosed with type 2
diabetes [9,10]. However, the present study focused on
effects among individuals without diabetes as these are
directly related to diabetes prevention rather than man-
agement. Yamaoka and Tango [11], Gillies et al. [12] and
Norris et al. [13] published meta-analyses summarizing
the efficacy of diet and exercise interventions among
adults with pre-diabetes or impaired glucose tolerance
(IGT). We decided to focus on lifestyle intervention ef-
fects irrespective of pre-diabetic risk categories. Evidence
suggesting the need for lower cutoff levels for diabetes
risk categories in Western populations [14] and includ-
ing more studies in the analyses provided the impetusfor this decision. Besides obtaining estimates of effect
sizes for overall lifestyle intervention, we were also inter-
ested in examining the effects of important intervention
aspects such as calorie and fat intake restrictions and
improvements in frequency and duration of exercise.
The objectives of the present meta-analyses were to
quantitatively summarize 1) overall effect size of lifestyle
education programs targeting both diet and physical ex-
ercise modifications and 2) effects of important dietary
and exercise attributes on FI, FG, SBP, HDL, TAG and
BMI in adults without diabetes in Western populations.
Methods
Literature search
Studies involving both diet and physical exercise inter-
ventions where FI, FG, SBP, TAG, HDL and/or BMI
were major outcome measures were searched. Study par-
ticipants were required to be from Western populations,
where the majority is Caucasian. This distinction was
made to minimize the potential heterogeneity of inter-
vention effects due to ethnic differences. Study partici-
pants in the control group were required to continue
with their regular exercise and dietary habits and not re-
ceive any diet or exercise counseling prior to or during
the study period. MEDLINE and EMBASE computer
searches [15] were carried out for articles describing hu-
man clinical trials published in English before June 30,
2012 using the keywords: “diet or weight loss”, “exercise
or physical activity”, “diabetes risk or cardiovascular
risk”, “obese or overweight” and “men and women”. Dif-
ferent combinations of key words were searched in both
MEDLINE and EMBASE (Table 1). A total of 894 (278
with MEDLINE and 616 with EMBASE) studies were re-
trieved from the computer searches. Six hand-searched
articles were additionally included (Figure 1). 474 dupli-
cates were removed leaving 420 records to be screened.
Two authors separately screened the abstracts of the 420
articles and excluded 137 articles because they were about
surveys, feasibility studies, trial designs or mathematical
and statistical model analyses (Figure 1). Moreover, some
of the excluded studies were not from Western countries.
The remaining 283 full text articles were assessed for
eligibility to be included. The eligibility criteria were 1) tri-
als included adult (men and/or women) participants who
were not diagnosed with diabetes, 2) intervention involved
both dietary and exercise counseling, 3) dietary counseling
targeted calorie and macronutrient intake modifications,
4) outcome measures included changes in diabetes risk
factors compared to a control group, 5) availability of mean
and variance measures of risk factor changes from baseline
in both control and intervention groups, and 6) availability
of information on macronutrient intake changes of inter-
vention and control participants. A total of 249 articles
were excluded as they did not meet the eligibility criteria
Table 1 Number of articles retrieved from MEDLINE and
EMBASE databases for different key word combinations
Keywords MEDLINE EMBASE
Diet, exercise, obese, diabetes risk, men, women 27 56
Diet, exercise, overweight, diabetes risk,
men, women
29 50
Diet, exercise, obese, cardiovascular risk,
men, women
32 63
Diet, exercise, overweight, cardiovascular risk,
men, women
34 69
Diet, physical activity, obese, diabetes risk,
men, women
29 67
Diet, physical activity, overweight, diabetes
risk, men, women
28 84
Diet, physical activity, obese, cardiovascular
risk, men, women
33 77
Diet, physical activity, overweight, cardiovascular
risk, men, women
31 97
Weight loss, exercise, obese, diabetes risk,
men, women
18 21
Weight loss , exercise, overweight, diabetes risk,
men, women
17 32
Figure 1 A schematic representation summarizing the literature searc
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ported risk factors for men and women separately. The
male and female groups in these reports were considered
two separate studies leaving 36 studies for quality assess-
ment. Quality of the selected studies was evaluated by
assessing the risk of four biases [18]: 1) selection bias
representing systematic differences between baseline char-
acteristics of intervention and control groups, 2) perform-
ance bias regarding exposure to factors other than the
interventions of interest, 3) attrition bias involving system-
atic differences between groups in withdrawals from a
study, and 4) publication bias assessed as described below.
Baseline characteristics of study participants were not con-
siderably different between control and intervention arms
in any of the 36 studies. Although some studies encour-
aged increased fiber intake and reduced cholesterol intake
besides macronutrient intake modifications, these studies
were kept in the dataset because fiber and cholesterol in-
take effects can be accounted for in the analyses as de-
scribed below. Most of the studies reported no systematic
differences between withdrawal groups. However, two arti-
cles were excluded because the studies had considerable
dropout rates (>30%) with no note on the similarities or dif-
ferences of the withdrawal groups (Figure 1). Although, the
statistical significance (P-values) of the intervention effects
did not change, the magnitude of the effect sizes changed
notably when these two studies were excluded. Sinceh.
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interventions regarding diabetes risk was the main ob-
jective of the present study, we proceeded with the
meta-analyses without these two studies. Therefore, the
final data set used for the meta-analyses contained 34
studies (Figure 1 and Table 2).
Data and variables
Data were extracted and put onto structured Excel data-
sheets designed to capture relevant information in a con-
cise manner. Two authors conducted the screening and
data extraction independently using a common set of in-
structions prepared for the relevant tasks. Sample size (N),
mean risk factor levels at baseline and standard deviation
(SD) of FI, FG, SBP, HDL, TAG and BMI changes during
intervention of the control and intervention arms were es-
sential to the analyses. Mean FI and BMI values were re-
corded in mU/L and kg/m2, respectively, while the other
risk factors were recorded in mmol/L. In the absence of a
reported SD, if 95% confidence intervals for the risk factor
changes were provided, the SD was calculated assuming
the changes were normally distributed. In a few cases, the
SD was calculated using the P-values for risk factor
changes from baseline and corresponding test statistics. N
was the number of participants completing each treatment
and undergoing post-treatment risk factor measurements.
Information on energy (kcal/d) and the macronutrients:
carbohydrate, protein, total fat, and saturated fat intake [%
of energy intake (%E)] at baseline and at the end of the
interventions were recorded in separate columns of the
datasheet. When the macronutrient intakes were re-
ported in g/d (along with daily energy intake), the %E
values were calculated using Atwater energy equivalents
[19]. Energy and macronutrient intake changes (from
baseline) in the control and intervention groups were cal-
culated separately. Difference (d) between these changes
mean values are given in Table 3 was then calculated and
used in the statistical models.
d ¼ Nutrient intake change in intervention
group–Change in control group
When the nutrient intake changes of control participants
were not available, they were assumed to be unchanged
from baseline during the interventions. With respect to ex-
ercise interventions, two explanatory variables: the number
of exercise sessions per week (ES) and minutes of exercise
per session (EM) were created. Two binary variables were
also created to represent presence or absence of dietary
counseling regarding fiber intake increase (FB) and choles-
terol intake reduction (CH). As some exercise intervention
programs included resistance training sessions, a binary
variable (ERT; 1 = presence or 0 = absence) was created to
examine the impact of resistance training on the diabetesrisk factors. When actual ES and EM measures were not
available, they were assumed to be equivalent to the exer-
cise intervention guidelines (Table 2). Some studies exclu-
sively recruited people with abnormalities such as impaired
glucose tolerance (IGT), insulin resistance (IR), or meta-
bolic syndrome (MetS). Another binary variable (ABN)
was created to identify studies that exclusively used partici-
pants with such abnormalities. Average age in years, study
duration in months and the fraction of women in the study
population (ranging from 0, only men to 1, only women)
were also extracted. When the biomarker levels were mea-
sured at multiple time points, the measures of the nutrient
intake at the latest time point were used. For some studies,
the selected time point was after a follow-up period. There-
fore, an additional binary variable (IFU) was generated to
represent presence or absence of a follow-up period.
Statistical analyses
Separate meta-analyses were conducted for each bio-
marker using the metafor (version 1.6-0) package in R
(version 2.12.2) [50]. Mean difference (MD) was chosen as
the effect size measure as it allows effect size interpret-
ation in the original units of risk factor measurement.
MD ¼ Meanrisk factor change Interventionð Þ−Mean
risk factor change Controlð Þ
This choice was further supported by the fact that the
metafor package allows for weighting individual studies
for corresponding sample variance as described below
[50]. The forest plots of each risk factor were also con-
structed using MD (Figures 2, 3, and 4). In addition to
MD, forest plots give average sample size, intervention
duration, and absolute risk factor changes in the control
and intervention arms.
Let:
yi ¼ θi þ ei
where yi is the observed effect size or MD in the i
th
study, θi is the corresponding (unknown) true effect size,
ei is the sampling error [ei ~N(0, vi)]. Sampling variances
(i.e., vi) are assumed to be known and remained fixed
during estimation in order to weight the individual stud-
ies when estimating model parameters [50]. Between-
study variability (heterogeneity) of the true effects θi was
assumed to be purely random, leading to random-effect
models given by:
θi ¼ μþ ui
where θi is the true effect size (e.g., MD) in the i
th study,
μ is the overall true effect size, and ui is the random
deviation from the overall effect size (ui ~N(0, τ
2)),
which was unknown but estimated from the data. The
true effects were normally distributed with mean μ and
Table 2 Summary description of the diet plus exercise intervention studies included in the analyses
Study Authors and
year
Country Age1 Women2 IGT/IR/
MetS3
BMI4 Diet intervention guidelines5 Exercise intervention
guidelines5
1 Straznicky et al.
2012 [20]
Australia 55 0.41 MS 32.7 ~650 kcal/d restriction, 22%
protein, 30% TF, 9% SF
aerobic (biking), 40 min/S,
3–4 S/wk
2 Blumenthal et al.
2010 [21]
USA 52 0.69 NA 33.3 ~500 kcal/d restriction, 27% TF aerobic (biking and walking),
40 min/S, 3–4 S/wk
3 Ibanez et al. 2010
[22]
Spain 50 1.00 NA 35.0 500 kcal/d restriction resistance training, 45–60 min/S,
2 S/wk
4 Straznicky et al.
2010 [23]
Australia 55 0.41 MS 32.4 ~500 kcal/d restriction, 30% TF,
9% SF
aerobic (biking), 40 min/S, 3 S/wk
5 Roumen et al.
2008 [24]
Netherlands 56 0.45 IGT 29.4 reduced caloric and reduced
fat diet
aerobic plus resistant training,
30 min/S, 5 S/wk
6 Herder et al. 2009
[25]
Finland 56 0.50 IGT 31.2 <30% TF, <10% SF endurance training, >30 min/S,
~6 S/wk
7 Mosca et al. 2008
[26]
USA 48 0.66 NA 28.1 low-SF and low-cholesterol diet moderate physical activity (brisk
walking), 30–60 min/S
8 Morgan et al.
2009 [27]
UK 41 0.74 NA 31.6 Rosemary Conley's controlled-
calorie low-fat diet
Rosemary Conley's Fitness plan
with weekly classes
9 Dale et al. 2009
[28]
New Zealand 46 0.67 IR 34.6 400 kcal/d restriction, 27% TF,
9% SF




Canada 43 1.00 NA 29.9 500 kcal/d restriction, high
protein (37%) diet
endurance training, 36 min/S,
3 S/wk
11 Burke et al. 2007
[30]
Australia 56 0.56 NA 30.1 <30% TF, <10% SF moderate intensity, 30 min/S,
most days/wk
12 Bo et al. 2007 [31] Italy 56 0.58 MS 30.0 reduced TF and SF intake moderate intensity (i. e. brisk
walking), ~150 min/wk
13 Arciero et al. 2006
[32]
USA 43 0.48 NA 27.8 high protein (40%) and low fat
(20%) diet
resistance and cardiovascular
training, 20 min/S, 4–6 S/wk
14 Brekke et al. 2005
[33]
Sweden 42 0.37 NA 26.1 <30% TF intake, <10% SF intake walking or more intensive
exercise, 30 min/S, 4–5 S/wk
15 Watkins et al. 2003
[34]
USA 50 0.50 NA 33.7 500 kcal/d restriction, <20% TF cycle ergometry and jogging, or
walking, ~60 min/S, 3–4 S/wk
16 Lindstrom et al.
2003 [35]
Finland 55 0.66 IGT 31.3 200 kcal/d restriction, <30% TF,
<10% SF
endurance exercise & resistance
training, >30 min/S
17 Esposito et al.
2003 [36]
Italy 35 1.00 NA 34.5 1400 kcal/d, 55% carbohydrate,
30% TF, <10% SF
aerobic exercise (walking and
swimming)
18 Mensink et al.
2003 [37]
Netherlands 56 0.43 IGT 29.5 >55% carbohydrate, <30% TF,
<10% SF
moderate physical activity,
>30 min/S, 5 S/wk
19 McAuley et al.
2002 [38]
New Zealand 46 0.71 IR 34.5 400 kcal/d restriction, 27% TF,
9% SF
Moderate exercise plus resistance
training, >20 min/S, 5 S/wk
20 Miller et al. 2002
[39]
USA 54 0.62 NA 33.7 500 kcal/d restriction, 27% TF,
6% SF
aerobic (brisk walking and
biking), 30–45 min/S, 3 S/wk
21 Reseland et al.
2001 [40]
Norway 45 0.00 MS 27.5 400 kcal/d restriction, <30% TF endurance exercise, 1 h/S, 3 S/wk
22 Oldroyd et al.
2001 [41]
UK 58 0.40 IGT 30.2 <30% TF intake, ~50%
carbohydrate
aerobic exercise, 20–30 min/S,
2–3 S/wk
23 Kuller et al. 2001
[42]
USA 47 1.00 NA 25.0 Calorie restriction upto 1300 kcal,
25% TF, 7% SF
increasing physical activity to
1250 kcal expended weekly
24 Ornish et al. 1998
[43]
USA 60 0.09 NA 26.9 10%-fat vegetarian diet moderate-intensity aerobic, 1 h/S,
5 S/wk
25 Stefanick et al.
1998 (female) [16]
USA 57 1.00 NA 25.6 <30% TF intake, <7% SF intake aerobic (jogging and brisk
walking), 60 min/S, 3 S/wk
26 Stefanick et al.
1998 (male) [16]
USA 48 1.00 NA 27.8 <30% TF intake, <7% SF intake aerobic (jogging and brisk
walking), 60 min/S, 3 S/wk
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Table 2 Summary description of the diet plus exercise intervention studies included in the analyses (Continued)
27 Wing et al. 1998
[44]
USA 46 0.78 NA 36.0 600-700 kcal/d restriction, 20% TF
intake
aerobic (brisk walking), 60 min/S,
5 S/wk
28 Simkin-Silverman
et al. 1995 [45]
UK 47 1.00 NA 25.1 <25% TF intake, <7% SF intake brisk walking spending
1000 kcal/wk, 3–5 S/wk
29 Hellenius et al.
1993 [46]
Sweden 46 0.00 NA 25.6 12% daily calorie and 10% TF
restriction
aerobic exercise, 30–45 min/S,
2–3 S/wk
30 Svendsen et al.
1993 [47]
Denmark 54 1.00 NA 29.7 800 kcal/d restriction, low fat
(25%) diet
aerobic plus resistant training,
75 min/S, 3 S/wk
31 Page et al. 1993
[48]
UK 40 0.23 IGT 25.9 50-55% carbohydrate, 30% TF,
high fiber
aerobic weight and circuit
training, swimming, >3 S/wk
32 Schuler et al. 1992
[49]
Germany 54 0.00 NA 26.6 <20% TF, 65% carbohydrate,
PUSF: SF ratio >1.0
daily exercise (75% MHR),
>30 min/S
33 Wood et al. 1991
(male) [17]
USA 38 0.00 NA 33.5 55% carbohydrate, 30% TF,
<10% SF
aerobic (brisk walking and
jogging), 35 min/S, 3 S/wk
34 Wood et al. 1991
(female) [17]
USA 38 1.00 NA 26.3 55% carbohydrate, 30% TF,
<10% SF
aerobic (brisk walking and
jogging), 35 min/S, 3 S/wk
1Average age of participants at baseline (years), 2fraction of women participants, 3whether participants had abnormalities such as impaired glucose tolerance (IGT),
insulin resistance (IR) and metabolic syndrome (MetS) or no abnormalities (NA), 4average BMI of participants at baseline (kg/m2), 5TF = Total fat (% of energy), SF =
Saturated fat (% of energy), and S = exercise session.
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true effects across individual studies such that μ=θ.
Heterogeneity (τ2) was expressed as a percentage of
total variability (τ2 plus sample variance) yielding I2
statistics.
An I2 value greater than 50% indicates considerable
heterogeneity. Thus, for response variables (e.g., interven-
tion effects on diabetes risk factors in the present study)
with I2 > 50%, the random-effect models were extended
to mixed-effect models including fixed effects of ex-
planatory variables (meta-regression analyses) with the
potential to explain the heterogeneity in intervention
effects. The mixed-effect models were given by:
θi ¼ β0 þ β1xi1 þ…þ βpxip þ ui
where β0 is the overall true effect size, xij is the the value
of the jth explanatory variable (j = 1, 2, …, p) for the ith
study, βj is the change in the true effect size for a unit
increase in the jth explanatory variable and ui ~N(0, τ
2).
Here, τ2 denotes the amount of residual heterogeneity
[50]. The parameters in the mixed-effect models
(β0, …, βp) were estimated via weighted least squares
with weights equal to 1/(vi + τ
2).
The candidate explanatory variables for the mixed-effect
models were energy and macronutrient intake changes,
the exercise attributes: ES, EM and ERT, baseline risk fac-
tor level, baseline age and BMI, time duration from base-
line to the post-intervention risk factor measurements, FB,
CH, ABN, IFU and fraction of women in the study popu-
lation. Each continuous explanatory variable was centered
on its mean before being used in the mixed-effect models.
This allows for interpreting the meta-regression coeffi-
cients in terms of changes in intervention effect size for aunit change in a continuous explanatory variable from its
mean. Mixed-effect models including individual explana-
tory variables were first fitted to the data. Full multivariate
mixed-effect models were then formed including all
explanatory variables having notable effects (P <0.10)
when fitted individually. Reduced models were formed
via stepwise elimination of one explanatory variable at a
time. The final mixed-effect models were chosen by com-
paring reduced models vs. full models using log-likelihood
ratio tests with the maximum likelihood method.
Publication bias and influence diagnosis
Publication bias and presence of influential cases can
affect the validity and robustness of the conclusions from
a meta-analysis [51,52]. Studies for which the effect size
estimates and their variability are extremely sensitive were
recognized using a leave-one-out approach. The leave1out
function in metafor package was used to execute this in-
fluence diagnostic analysis, which is equivalent to a sensi-
tivity analysis. Cook’s distance and τ2 estimates (τ2D) were
obtained when each study was excluded from the data set.
[50]. If a study was related to a Cook’s distance >2 and τ2D
two SD below the mean τ2D of the other studies, that study
was removed from the dataset. Initially, 19, 25, 25, 31, 30,
and 30 of the 34 studies were chosen for FI, FG, SBP,
HDL, TAG and BMI analyses respectively, but after the in-
fluence analyses 18, 24, 23, 30, 29, and 29 studies were
retained, respectively. Presence of publication bias was
assessed using funnel plots. Asymmetric funnel plots indi-
cate the presence of publication bias. Egger’s regression
test was used to examine funnel plot asymmetry [50].
None of the funnel plots was found to be significantly
asymmetric (P-values for funnel plot asymmetry >0.05) in-
dicating absence of publication bias in all cases.
Figure 2 Forest plots showing absolute fasting insulin (A) and fasting glucose (B) changes (from baseline) in control and intervention
arms, average sample size (N) across both arms, time duration related to the changes and mean difference of changes with its
confidence interval (95% CI).
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Study characteristics
Of the 34 studies included in meta-analyses, 16, 13, and 5
studies were from Europe, North America, and Australia
and New Zealand, respectively (Table 2). Information
about ethnic composition of participants was not available
in all the articles. Based on the articles reporting the eth-
nic composition, >60% of the study participants wereCaucasian. Average age at baseline ranged from 35 to
60 years with a mean of 49 years, indicating that the ma-
jority of study participants were middle-aged. Twenty of
the 34 studies recruited exclusively overweight and obese
individuals. Average baseline BMI varied from 25.0 to
36.0 kg/m2 with a mean of 30.2 kg/m2 (Table 3). Twelve
of the 34 studies examined diet plus exercise intervention
specifically in adults with abnormalities such as IGT, IR,
Figure 3 Forest plots showing absolute systolic blood pressure (A) and body mass index (B) changes (from baseline) in control and
intervention arms, average sample size (N) across both arms, time duration related to the changes and mean difference of changes
with its confidence interval (95% CI).
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studies ranged between 4.83 and 6.20 mmol/L, with a
mean of 5.55 mmol/L. The respective FI range was 3.0
and 24.1 mU/L with a mean of 14.9 mU/L. Time durationfrom baseline risk factor measurements to the post-
intervention measurements varied from 2 to 60 months
with a mean of 14 months (Table 3). In a few studies,
this duration included a follow-up period in addition to
Figure 4 Forest plots showing absolute high density lipoprotein (A) and triacylglyceride (B) changes (from baseline) in control and
intervention arms, average sample size (N) across both arms, time duration related to the changes and mean difference of changes
with its confidence interval (95% CI).
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included only female participants and four used only
males while the rest (21 studies) included both malesand females. The majority of lifestyle intervention pro-
grams aimed to restrict energy intake by 500 kcal/d,
total fat ≤30%E, and saturated fat ≤10%E (Table 2) and
Table 3 Summary statistics for variables across the 34
studies included in the meta-analyses
Variable Mean ± SD1 Minimum Maximum
Energy and macronutrient intake
at baseline
Calorie intake, kcal/d 2100 ± 260 1583 2900
Carbohydrate, %E 46.6 ± 5.0 36.5 58.5
Protein, %E 17.2 ± 2.6 12.3 25
Fat, %E 34.7 ± 3.3 27.5 43.5
Saturated fat, %E 12.9 ± 1.8 9 16.6
Energy and macronutrient intake
changes of intervention participants2
Calorie intake, kcal/d −273 ± 169 −828 49.5
Carbohydrate, %E 2.9 ± 5.7 −14 11
Protein, %E 3.3 ± 5.6 −3.8 21.3
Fat, %E −6.3 ± 3.8 −16.5 0.4
Saturated fat, %E −2.9 ± 2.0 −8 0.0
Exercise intervention
Number of sessions per week 4 ± 1.0 2 7
Session length (minutes) 41 ± 13 20 75
Risk factor level measurements
at baseline
FI 14.9 ± 5.4 3.0 24.1
FG 5.55 ± 0.4 4.83 6.20
SBP 128 ± 10 110 143
HDL 1.25 ± 0.2 0.89 1.74
TAG 1.76 ± 0.9 0.85 5.84
BMI 30.2 ± 3.3 25.0 36.0
Age at baseline, years 49 ± 7 35 60
Fraction of women participants 0.59 ± 0.3 0 1
Duration of intervention
(months)3
14 ± 3.5 2 60
1SD, Standard deviation.
2Change from baseline compared to that of control participants.
3Duration from baseline to the risk factor level measurements used in
the analyses.
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aerobic exercises such as brisk walking, jogging, cycling,
and swimming. About one-third of the intervention
programs included instructions for resistance training.
Overall, the intervention programs involved an average
of 4 exercise sessions a week each lasting 41 minutes
(Table 3).
Heterogeneity
Random-effect model analyses (Table 4) revealed sub-
stantial heterogeneity (τ2, P <0.001) of lifestyle interven-
tion effects on all risk factors. The I2 estimates (τ2/τ2 +
sample variance) were >99.0% in all cases (Table 4) indi-
cating that between-study variability of intervention ef-
fects (τ2) were >110 times greater than within-studyvariability (sample variance). Therefore the random-effect
models were extended to mixed-effect models to explore
heterogeneity.
Intervention effect size estimates from mixed-effect models
Calorie intake restrictions, abnormalities such as IGT or
IR, and resistance training exercises influenced FI re-
sponses to lifestyle interventions (P <0.10) and accounted
for 60% of the heterogeneity [τ2 = 3.762 (Table 4) vs. 1.523
(Table 5)]. Lifestyle interventions reduced FI by 2.56 ±
0.58 mU/L (Table 5) in normal adults engaging in mod-
erate intensity aerobic exercise. This decrease in FI was
related to a mean 273 kcal/d restriction (Table 3). The
negative parameter estimate of calorie restriction in
Table 5 shows that an additional 100 kcal/d restriction
would have reduced FI by an additional 0.68 ± 0.26 mU/
L. On the other hand, incorporation of resistance train-
ing into the exercise intervention impeded the expected
FI decline by 1.72 ± 0.81 mU/L. Hence, the expected FI
change among adults engaging in resistance training
was −0.84 mU/L (−2.56 + 1.72 mU/L). Regardless of the
degree of calorie restriction and exercise intensity,
adults with metabolic abnormalities tended (P = 0.082)
to experience an extra FI reduction of 1.20 ± 0.69 mm Hg
(Table 5).
Diet plus exercise interventions reduced FG by 0.18 ±
0.04 mmol/L (P <0.001) in normoglycemic healthy adults.
The metabolic abnormality and follow-up period variables
considerably explained the heterogeneity of the inter-
vention effects on FG. Heterogeneity was reduced by
23% when these factors were included in the final model
(τ2 = 0.013 vs. 0.010). Participants experienced less (by
0.13 ± 0.06 mmol/L) FG decline as they entered a
follow-up period, during which rigorous intervention
counselling was not provided. Regardless of undergoing
a follow-up period or not, adults with metabolic abnor-
malities tended (P = 0.098) to experience a greater FG
decline (by 0.08 ± 0.05 mmol/L) compared to normal
adults (Table 5). Diet and exercise interventions reduced
SBP by 2.77 ± 0.56 mm Hg (P <0.001, Table 5). However,
study participants with abnormalities experienced an
extra SBP decline of 3.23 ± 1.00 mm Hg (Table 5). Ex-
tending intervention by a month reduced the expected
SBP decline by 0.13 ± 0.03 mm Hg. Calorie restriction
increased by 100 kcal/d was associated with an additional
SBP decline of −0.64 ± 0.23 mm Hg (P = 0.006). Presence
or absence of abnormalities, intervention duration, and
degree of calorie intake restriction explained collectively
63% [τ2 = 7.474 (Table 4) vs. 2.796 (Table 5)] of hetero-
geneity of the intervention effect on SBP.
The diet plus exercise interventions did not have a sig-
nificant impact (P = 0.305) on HDL (Table 5). Nonetheless,
age of participants at baseline and percentage of women
in the study population explained 29% of heterogeneity in
Table 4 Heterogeneity (τ2) of lifestyle intervention effects and statistical significance of funnel plot asymmetry from
random-effect models
Risk factor1 Number of
studies included
N2 Heterogeneity2 Funnel plot
asymmetry (P-value)3I2(%)2 τ2 P-value
FI (mU/L) 18 1756 99.5 3.762 ± 1.511 <0.001 0.519
FG (mmol/L) 24 3897 99.4 0.013 ± 0.005 <0.001 0.774
SBP (mm Hg) 23 3443 99.4 7.474 ± 2.894 <0.001 0.771
HDL (mmol/L) 30 4218 99.8 0.007 ± 0.002 <0.001 0.577
TAG (mmol/L) 29 3908 99.8 0.050 ± 0.015 <0.001 0.855
BMI (kg/m2) 29 4160 99.8 0.881 ± 0.256 <0.001 0.587
1FI: Fasting insulin, FG: Fasting glucose, SBP: Systolic blood pressure, HDL: High density lipoprotein, TAG: Triacylglyceride, BMI: Body mass index.
2total number of participants, who concluded the interventions.
2I2 = heterogeneity (τ2) expressed as a percentage of total variance (τ2 + sample error).
3From Egger’s regression test.
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control participants. The lifestyle interventions reduced
TAG by 0.258 ± 0.037 mmol/L (P <0.001). This drop in
TAG was related to a mean net energy intake restriction
of 273 kcal/d and a mean baseline TAG of 1.76 mmol/L
(Table 3). An additional 100 kcal/d energy restriction
would have further improved the decrease in TAG by
0.061 ± 0.017 mmol/L. A unit increase in TAG at baseline
was associated with an additional TAG drop of 0.243 ±
0.076 mmol/L.
Adult participants experienced a 1.61 ± 0.13 kg/m2
(P <0.001) BMI decline when engaged in a diet plus
exercise lifestyle intervention program. The extent ofTable 5 Estimates of intervention effect size and total amoun
models
Risk factor1 Overall effect size Effect size change for int
Estimate ± SE P-value Explanatory Variables2
FI (mU/L) −2.56 ± 0.58 <0.001 Presence of IGT, IR or MetS
Calorie restriction (100 kcal/d
Incorporation of resistance tr
FG (mmol/L) −0.18 ± 0.04 <0.001 Presence of IGT, IR or MetS
After a follow-up period
SBP (mm Hg) −2.77 ± 0.56 <0.001 Presence of IGT, IR or MetS
Calorie restriction (100 kcal/d
Length of intervention (mont
HDL (mmol/L) −0.015 ± 0.015 0.305 Age at baseline (years)
Fraction of women participan
TAG (mmol/L) −0.258 ± 0.037 <0.001 Calorie restriction (100 kcal/d
Baseline TAG (mmol/L)
BMI (kg/m2) −1.61 ± 0.13 <0.001 Calorie restriction (100 kcal/d
Fat intake restriction (% Energ
Exercise session duration (10
Baseline BMI (kg/m2)
1FI: Fasting insulin, FG: Fasting glucose, SBP: Systolic blood pressure, HDL: High dens
2IGT = Impaired glucose tolerance, IR = Insulin resistance and MetS =Metabolic synd
3Standard error of the estimate.calorie and total fat intake restrictions, duration of exer-
cise sessions, and baseline BMI considerably affected the
degree of BMI change (P <0.060, Table 5). An extra
100 kcal/d energy intake restriction, a unit increase in
total fat intake restriction and an additional 10 minutes of
exercise would have further reduced BMI by 0.22 ± 0.08,
0.10 ± 0.03 and 0.24 ± 0.12 kg/m2, respectively. Obese
adults appeared to respond more to the interventions than
normal and overweight adults because a unit increase in
BMI at baseline from the mean (30.1 kg/m2) was associ-
ated (P = 0.095) with an additional 0.07 ± 0.04 kg/m2 BMI
decline. The final mixed-effect model including calorie
and fat restrictions, exercise duration, and BMI at baselinet of residual heterogeneity (τ2) from final mixed-effect
ervention attributes and other factors Residual heterogeneity
Estimate ± SE3 P-value τ2 P-value
−1.20 ± 0.69 0.082 1.523 ± 0.773 <0.001
) −0.68 ± 0.26 0.009
aining 1.72 ± 0.81 0.034
−0.08 ± 0.05 0.098 0.010 ± 0.004 <0.001
0.13 ± 0.06 0.034
−3.23 ± 1.00 0.001 2.796 ± 1.419 <0.001
) −0.64 ± 0.23 0.006
hs) 0.13 ± 0.03 <0.001
−0.006 ± 0.002 0.021 0.005 ± 0.002 <0.001
ts −0.086 ± 0.046 0.065
) −0.061 ± 0.017 <0.001 0.029 ± 0.009 <0.001
−0.243 ± 0.076 0.001
) −0.22 ± 0.08 0.003 0.353 ± 0.125 <0.001
y) −0.10 ± 0.03 0.003
min) −0.24 ± 0.12 0.055
−0.07 ± 0.04 0.095
ity lipoprotein, TAG: Triacylglyceride, BMI: Body mass index.
rome.
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effect on BMI [τ2 = 0.881 (Table 4) vs. 0.353 (Table 5)].
Discussion
Although meta-analytic applications are increasingly used
to summarize results from clinical trials, much uncertainty
remains about which approach to use, particularly when
significant between-study variability of results or hetero-
geneity is present [53]. Random-effect methods provide an
attractive approach for summarizing heterogeneous re-
sults [53]. The lifestyle intervention effects of individual
studies included in the present meta-analyses were very
heterogeneous (Figures 2, 3 and 4). Therefore, the overall
effect sizes and total amount of heterogeneity (τ2) was
estimated using random-effect approaches. In addition to
determining the overall effect size, random-effect ap-
proaches allow for exploring factors responsible for het-
erogeneity. These approaches involve mixed-effect models
and are similar to meta-regression approaches. Thus,
mixed-effect models were used to explore heterogeneity
and estimate the impacts of important attributes of life-
style interventions on risk factor changes. Such estimates
are difficult to find in the literature but would improve
diabetes risk prediction models. For example, Appuhamy
and colleagues [54] developed a mathematical model for
predicting diabetes incidence using BMI. Incorporating
the effect size estimates of BMI (Table 5) should enable
their model to predict diabetes incidence changes in
response to lifestyle modifications. The present meta-
analyses summarized effects of lifestyle modifications
on other diabetes risk factors such as FI, FG, SBP, HDL
and TAG. These factors are also used in mathematical
models for predicting diabetes risk [5-7].
Fasting insulin in normoglycemic adults is an import-
ant predictor of diabetes risk independent of whether
they have insulin resistance or not [55]. Thus, lowering
FI could be an option in primary diabetes prevention [55].
The present meta-analyses showed that non-diabetic
adults engaging in a diet plus exercise intervention pro-
gram experienced a 17% reduction in FI from baseline. Al-
though dietary guidelines in the studies advocate on
average a 500 kcal/d energy restriction, the average net en-
ergy intake reduction among intervention participants was
273 kcal/d. A greater compliance with calorie restriction
would have further decreased FI because FI was found to
decrease linearly by 0.68 mU/L for each additional
100 kcal/d reduction. Hence an actual 500 kcal/d energy
restriction would have reduced FI by 4.10 mU/L. Partici-
pants with impaired glucose tolerance or insulin resistance
had their FI improved to a greater extent than normal par-
ticipants. When resistance training was incorporated into
moderate intensity aerobic exercises, the expected FI im-
provement for lifestyle interventions was significantly re-
duced by 1.72 mU/L. This agrees with Holten et al. [56]who demonstrated that strength training could increase FI
levels in non-diabetic adults.
Fasting glucose is often used in diabetes risk prediction
models [57], although plasma glucose based on the oral
glucose tolerance test (OGTT) or the IGT test (IGTT)
would better predict diabetes risk [58]. The greater cost
and inconvenience associated with these tests generally
impede their use in diabetes prediction models [59]. Fur-
thermore, we chose FG over OGTT and IGTT-based
glucose because FG was measured in many of the
searched studies. Diet and exercise interventions were
associated with a decline in FG of 0.18 mmol/L, repre-
senting a 3% drop from baseline (P <0.001). Elevating FG
from normoglycemic levels to impaired fasting glucose
(IFG) levels doubles the risk of developing diabetes
[60,61]. The mean baseline FG of 5.55 mmol/L indicates
that many of the study participants were at a high risk of
developing diabetes especially considering the fact that the
current cutoff for IFG (5.60 mmol/L) needs to be reduced
for some Western populations [14]. Therefore, this 3% FG
reduction should delay diabetes development in Western
adults. Our results showed that continuous dietary coun-
selling and physical activity improvement were necessary
for a persistent FG decline. Moreover, the FG levels of
adults with abnormalities such as IGT or MetS improved
more than those of normal adults.
Hypertension is recognized as an independent pre-
dictor of diabetes incidence in various populations. Sys-
tolic blood pressure above 120 mm Hg is associated
with twice the diabetes risk of SBP below 100 mm Hg
[62]. The present meta-analyses showed that diet plus ex-
ercise intervention counseling reduced (P <0.001) SBP by
2.77 mm Hg. This decline in SBP could be associated with
a considerable reduction in diabetes risk as Dotevall et al.
[63] reported a 0.10 diabetes hazard ratio increase for
every unit increase in SBP above 130 mm Hg. Normogly-
cemic adults with abnormalities such as IGT or MetS
experienced greater declines in SBP, suggesting more life-
style intervention benefits for them than for ordinary
adults. An improved compliance with calorie restriction
guidelines, particularly as the intervention program pro-
gressed, could have resulted in a greater SBP decline.
Dyslipidaemia, characterized by elevated TAG and re-
duced HDL, is usually associated with increased risk of
developing diabetes mellitus [64]. Diet plus exercise in-
terventions reduced TAG by 0.258 mmol/L (P <0.001).
This could be associated with a considerably reduced
risk of developing diabetes as Tirosh et al. [65] reported
a 13% reduction in diabetes risk for each 0.20 mmol/L
decline in TAG in non-diabetic men. The declines in
TAG were greater as baseline TAG levels increased,
suggesting more lifestyle intervention benefits for dys-
lipidaemic adults than normolipidaemic adults. Greater
calorie restrictions further enhanced the TAG declines,
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When summarized over 30 studies, diet plus exercise in-
terventions did not have a significant impact on HDL.
Fourteen studies were associated with reduced HDL (the
negative mean differences in Figure 4A) while the rest
showed zero or positive responses. Differences in baseline
age and percentage of women in the study population
explained 29% of the heterogeneity in HDL responses to
lifestyle interventions.
Body mass index is a leading diabetes risk predictor
as evidenced by the high correlation between obesity
and diabetes prevalence. Curioni and Lourenco [67]
and Schaar et al. [68] have summarized diet plus exercise
intervention effects on weight loss in adults regardless of
diabetes status. These analyses together examined 22
studies and found significant weight loss in response to
intervention. We found a consistent reduction in BMI
(P <0.001) of 1.61 kg/m2 (5.3% from baseline BMI) for diet
plus exercise interventions. Such a BMI reduction could
be associated with a considerable reduction in diabetes
risk as Chiu et al. [69] estimated a 30% diabetes incidence
drop in response to a BMI reduction from 30.0 to 28.0 kg/
m2. Moreover, the mathematical model developed by
Appuhamy et al. [53] predicts that a 1.61 kg/m2 in BMI
decline can lead to a 20% diabetes incidence reduction
in non-diabetic middle-aged adults. The heterogeneity
in lifestyle intervention effect on BMI was significant
(Figure 2B and Table 4). However, degrees of calorie and
total fat intake restrictions, duration of exercise and
BMI at baseline explained 60% of the heterogeneity. An
additional 100 kcal/d calorie intake reduction, an extra
unit reduction in total fat intake, and extending the ex-
ercise session length by 10 minutes could collectively
result in an additional 0.56 kg/m2 decline in BMI. BMI
decline significantly improved as baseline BMI increased,
suggesting greater lifestyle intervention benefit for obese
adults than for adults of normal weight.
Considerable unexplained heterogeneity still remained
(residual heterogeneity estimates in Table 5), indicating
that factors other than those taken into consideration in
the present analyses could be responsible for between-
study variability of lifestyle intervention effects. In addition
to carbohydrate, fat and protein as explanatory variables,
the present meta-analyses also accounted for saturated fat
and cholesterol intake restrictions, and fiber intake im-
provements. However, they did not significantly (P >0.10)
explain heterogeneity of lifestyle intervention effects. Data
on food sources of fatty acids could have explained hetero-
geneity to some extent [70,71] but availability of such data
was extremely limited in the studies considered. Represen-
tations of exercise intensity (e.g., percent maximum heart
rate and percent maximum oxygen consumption) may
have explained some of the heterogeneity. Furthermore,
representation of degree of compliance with diet andexercise guidelines [72] and ethnic composition of partici-
pants [73] could have further explained heterogeneity. As
the selected articles [20-49] did not consistently report
sufficient information to create such variables, we were
unable to explore their contribution to heterogeneity.
In summary, lifestyle interventions targeting calorie
and total fat intake restrictions and increase in moderate
intensity aerobic exercises were associated with significant
improvements in diabetes risk factors among normogly-
cemic adults. Differences in some intervention attributes
such as energy and fat intake restrictions, exercise type
and session duration, length of intervention, and baseline
characteristics of study participants accounted for 23-63%
of the heterogeneity. Having explained such proportions
of heterogeneity, lifestyle interventions were associated
with significant declines in FI, FG, SBP, TAG, and BMI of
2.56 mU/L, 0.18 mmol/L, 2.77 mm Hg, 0.258 mmol/L,
and 1.61 kg/m2 respectively in healthy normoglycemic
adults. However, normoglycemic adults having abnormal-
ities such as IGT, insulin resistance, metabolic syndrome
or hyperlipidemia appeared to benefit more from diet plus
exercise intervention programs than healthy normogly-
cemic adults.
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